Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Bratslavsky on the Evaluation and Management of Kidney Cancer

Gennedy Bratslavsky, MD
Published: Monday, May 15, 2017



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.



Gennedy Bratslavsky, MD, deputy director of Upstate Cancer Center, director of the Robotic Program for all Upstate Campuses, and director of the VHL Clinical Cancer Center, discusses the evaluation and management of kidney cancer.

Not every patient who presents with bilateral kidney cancer will have a genetic disorder, explains Bratslavsky.

Having knowledge of a specific histology from a biopsy, may help further direct the patient to additional genetic testing.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x